Almira Kurbegovic
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Modeling Pkd1 gene-targeted strategies for correction of polycystic kidney disease.
Journal: Molecular therapy. Methods & clinical development
Published: February 13, 2025
Kcnn4/KCa3.1 inhibition blunts polycystic kidney disease progression in mouse models.
Journal: JCI insight
Published: January 27, 2025
Eliosin-an alternative product from the HmPKD1 locus is a component of endoplasmic reticulum mitochondria membrane contact sites.
Journal: PloS one
Published: December 12, 2024
Modeling Pkd1 gene-targeted strategies for correction of polycystic kidney disease.
Journal: Molecular therapy. Methods & clinical development
Published: September 02, 2022
The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
Journal: Cellular signalling
Published: February 04, 2020
c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
Journal: Human molecular genetics
Published: May 24, 2018
Acute kidney injury induces hallmarks of polycystic kidney disease.
Journal: American journal of physiology. Renal physiology
Published: March 17, 2016
Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney disease.
Journal: Molecular and cellular biology
Published: June 25, 2014
Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
Journal: Human molecular genetics
Published: February 27, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026